| Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis (NCT00566618) | M.D. Anderson Cancer Center | 2007-11-01 |
| Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients (NCT00562224) | Pharmacyclics LLC. | 2007-11-01 |
| Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009) (NCT00567112) | Merck Sharp & Dohme LLC | 2007-11-01 |
| Patient Tolerability Study of GSK163090 (NCT00559299) | GlaxoSmithKline | 2007-11-01 |
| Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma (NCT00594126) | Geron Corporation | 2007-11-01 |
| Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia (NCT00665990) | St. Jude Children's Research Hospital | 2007-11-01 |
| Drug Interaction Study Between AZD3480 and Cytochrome P450 (NCT00692510) | AstraZeneca | 2007-11-01 |
| Study Evaluating FXR-450 in Healthy Japanese Men (NCT00509756) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-11-01 |
| A Phase I/II Study of Dasatinib and Dacarbazine (NCT00597038) | H. Lee Moffitt Cancer Center and Research Institute | 2007-11-01 |
| Study of Veltuzumab (hA20) at Different Doses in Patients With ITP (NCT00547066) | Gilead Sciences | 2007-11-01 |
| Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) (NCT00587990) | Joshua M Hare | 2007-11-01 |
| Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults (NCT00557583) | Virobay Inc. | 2007-11-01 |
| Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study (NCT00846092) | Medical College of Wisconsin | 2007-11-01 |
| Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC (NCT00544648) | Vanderbilt-Ingram Cancer Center | 2007-11-01 |
| Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma (NCT00561418) | Ohio State University Comprehensive Cancer Center | 2007-11-01 |
| Dose Response and Efficacy of GW842166 in Pain (NCT00554762) | GlaxoSmithKline | 2007-11-01 |
| A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors (NCT00570284) | Novartis Pharmaceuticals | 2007-11-01 |
| Healthy Volunteer Study of Clopidogrel and Rifampicin (NCT00696566) | Sheffield Teaching Hospitals NHS Foundation Trust | 2007-11-01 |
| Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma (NCT00571298) | Brigham and Women's Hospital | 2007-11-01 |
| Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors (NCT00516451) | Bristol-Myers Squibb | 2007-11-01 |
| Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI (NCT00565591) | Respirics Inc. | 2007-11-01 |
| Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial (NCT01372644) | NYU Langone Health | 2007-11-01 |
| HPPH and PDT for Pleural Malignancy (NCT01673074) | Abramson Cancer Center at Penn Medicine | 2007-11-01 |
| Drug Interaction With Metformin (NCT00546741) | AstraZeneca | 2007-11-01 |
| A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection (NCT02066428) | Aeras | 2007-11-01 |
| Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma (NCT00626704) | Amgen | 2007-11-01 |
| Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma (NCT00566098) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-11-01 |
| 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides (NCT00469547) | University of Washington | 2007-11-01 |
| ABI-008 Trial in Patients With Metastatic Breast Cancer (NCT00531271) | Celgene | 2007-11-01 |
| Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty (NCT00548288) | General and Teaching Hospital Celje | 2007-11-01 |
| Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors (NCT00881166) | Astex Pharmaceuticals, Inc. | 2007-11-01 |
| Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP (NCT00565370) | Asan Medical Center | 2007-11-01 |
| A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant (NCT00606268) | Astellas Pharma Inc | 2007-11-01 |
| Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma (NCT00598169) | AIDS Malignancy Consortium | 2007-11-01 |
| Efficacy of a New Topical Anesthetic (NCT00562211) | Rambam Health Care Campus | 2007-11-01 |
| Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma (NCT00613054) | Annick Desjardins | 2007-11-01 |
| Phase I, Open Label, Single Center Safety Study of [F-18]FLT (NCT00553748) | Siemens Molecular Imaging | 2007-11-01 |
| Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia (NCT00780143) | PharmaMar | 2007-11-01 |
| Human Mass Balance Study With Bilastine (NCT00572611) | Faes Farma, S.A. | 2007-11-01 |
| Open Label, Dose Escalation Phase I Study of AZD2281 (NCT00572364) | AstraZeneca | 2007-11-01 |
| A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors. (NCT00532090) | Hoffmann-La Roche | 2007-11-01 |
| Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage (NCT00968227) | Washington University School of Medicine | 2007-11-01 |
| Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease (NCT00553969) | University of Minnesota | 2007-11-01 |
| In Vivo Quantification of Dental Demineralisation Using OCT With and Without Esomeprazole (NCT00564330) | Brain-Gut Research Group | 2007-11-01 |
| Evaluation of KX2-391 in Patients With Advanced Malignancies (NCT00658970) | Athenex, Inc. | 2007-11-01 |
| Safety Study of Lactobacillus Administered Vaginally to Healthy Women (NCT00537576) | Osel, Inc. | 2007-11-01 |
| A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy (NCT00555516) | Tri-Service General Hospital (TSGH) | 2007-11-01 |
| A Study of LY2090314 in Patients With Advanced or Metastatic Cancer (NCT01287520) | Eli Lilly and Company | 2007-11-01 |
| Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects (NCT00619346) | Immtech Pharmaceuticals, Inc | 2007-11-01 |
| Study of AS902330 (rhFGF-18) Administered Intra-articularly in Patients With Knee Primary Osteoarthritis Who Are Candidates for Total Knee Replacement (NCT00911469) | Merck KGaA, Darmstadt, Germany | 2007-11-01 |
| Pain Control in Renal Colic (NCT00646061) | Seoul National University Hospital | 2007-11-01 |
| A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels (NCT00613249) | International Partnership for Microbicides, Inc. | 2007-11-01 |
| Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study (NCT01018420) | Mutual Pharmaceutical Company, Inc. | 2007-11-01 |
| Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy (NCT00561834) | University of Colorado, Denver | 2007-11-01 |
| Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00558727) | Spectrum Pharmaceuticals, Inc | 2007-11-01 |
| Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy (NCT00634998) | Washington State University | 2007-11-01 |
| Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal Women (NCT00543790) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-11-01 |
| Four Arm Food Effect Study of Fenofibric Acid Tablets (NCT00960856) | Mutual Pharmaceutical Company, Inc. | 2007-11-01 |
| Multipeptide Vaccine for Advanced Breast Cancer (NCT00573495) | University of Pennsylvania | 2007-11-01 |
| Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) (NCT00530699) | AstraZeneca | 2007-11-01 |
| Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition (NCT01603134) | IPCA Laboratories Ltd. | 2007-11-01 |
| Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer (NCT00593060) | Jeffrey W. Clark, MD | 2007-11-01 |
| A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste (NCT00762151) | Pfizer | 2007-11-01 |
| Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer (NCT00601510) | Technical University of Munich | 2007-11-01 |
| Sorafenib/Docetaxel Dose Escalation Trial (NCT00562523) | Bayer | 2007-11-01 |
| Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection (NCT00575185) | University of Minnesota | 2007-11-01 |
| A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects (NCT00546715) | Bristol-Myers Squibb | 2007-11-01 |
| A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects (NCT00559884) | GlaxoSmithKline | 2007-11-01 |
| A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia (NCT00580242) | Massachusetts General Hospital | 2007-11-01 |
| Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil (NCT00566865) | Elixir Pharmaceuticals | 2007-11-01 |
| Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions (NCT00857428) | Sandoz | 2007-11-01 |
| Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection (NCT00623649) | Vertex Pharmaceuticals Incorporated | 2007-11-01 |
| Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Non-Fasting Conditions (NCT01283867) | Dr. Reddy's Laboratories Limited | 2007-11-01 |
| Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones (NCT00556400) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2007-11-01 |
| Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics (NCT00607230) | Massachusetts General Hospital | 2007-11-01 |
| A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot (NCT01870999) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2007-11-01 |
| Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations (NCT00676039) | University of Ottawa | 2007-11-01 |
| Heliox in Experimental Upper Airway Obstruction (NCT00788788) | University of Witten/Herdecke | 2007-11-01 |
| A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1 (NCT01373606) | Ferring Pharmaceuticals | 2007-11-01 |
| A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects (NCT00785668) | Aerovance, Inc. | 2007-11-01 |
| Safety Study of CD-NP in Heart Failure (NCT00557661) | Nile Therapeutics | 2007-11-01 |
| Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer (NCT00623064) | European Organisation for Research and Treatment of Cancer - EORTC | 2007-11-01 |
| Effect of Regular Exercise in Prevention of Excessive Weight Gain in Pregnancy (NCT00617149) | Norwegian School of Sport Sciences | 2007-11-01 |
| Biomarkers of Muscle Anabolism (MK-0000-082) (NCT00812396) | Merck Sharp & Dohme LLC | 2007-11-01 |
| Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer (NCT00557362) | University of California, San Francisco | 2007-11-01 |
| Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors (NCT00676949) | Kyushu University | 2007-11-01 |
| [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors (NCT00707343) | University of Utah | 2007-10-31 |
| Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System (NCT00520130) | National Cancer Institute (NCI) | 2007-10-30 |
| Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00486603) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-10-29 |
| Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects (NCT00605852) | GlaxoSmithKline | 2007-10-29 |
| Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy (NCT00159250) | Imperial College London | 2007-10-26 |
| CP-690,550 Thorough QTc Study (NCT01743677) | Pfizer | 2007-10-26 |
| A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced Malignancies (NCT00651664) | Millennium Pharmaceuticals, Inc. | 2007-10-22 |
| Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease (NCT00792740) | Italfarmaco | 2007-10-22 |
| A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State (NCT00537654) | GlaxoSmithKline | 2007-10-18 |
| Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs (NCT00541970) | GlaxoSmithKline | 2007-10-17 |
| Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) (NCT00562640) | Memorial Sloan Kettering Cancer Center | 2007-10-16 |
| Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug (NCT00608335) | Astellas Pharma Inc | 2007-10-14 |
| A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis (NCT00591318) | Research Foundation for Mental Hygiene, Inc. | 2007-10-10 |
| Bevacizumab in Multiple Phase I Combinations (NCT00543504) | M.D. Anderson Cancer Center | 2007-10-10 |